Drug Abuse Monitoring: Which Pharmacoepidemiological Resources at the European Level?
Therapie, 70 2 (2015) 157-165
Published online: 2015-04-09
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Morbimortality consequences of use and misuse of psychoactive medicines in Portugal
Ana Carmona Araújo, Jose Pedro Guerreiro, Carolina Bulhosa, Ana Paula Martins, Filipa Alves da Costa and João GoulãoBritish Journal of Clinical Pharmacology 91 (11) 3225 (2025)
https://doi.org/10.1002/bcp.70171
Smartphone swabs as an emerging tool for toxicology testing: a proof-of-concept study in a nightclub
Théo Willeman, Justine Grunwald, Marc Manceau, Frédéric Lapierre, Lila Krebs-Drouot, Coralie Boudin, Virginie Scolan, Hélène Eysseric-Guerin, Françoise Stanke-Labesque and Bruno RevolClinical Chemistry and Laboratory Medicine (CCLM) 62 (9) 1845 (2024)
https://doi.org/10.1515/cclm-2024-0242
Misuse of psychoactive medicines and its consequences in the European Union – a scoping review
Ana Carmona Araújo, Rita João Casal, João Goulão and Ana Paula MartinsJournal of Substance Use 29 (4) 629 (2024)
https://doi.org/10.1080/14659891.2023.2213325
Case Report: the Comorbidity of Pregabalin-Use Disorder and Post-Traumatic Stress Disorder: Clinical and Pharmacological Issues
Gaël Galliot, Camille Ponté, Laurent Schmitt, Yann Hakimi, Sami Sergent, Maryse Lapeyre-Mestre and Juliette SallesInternational Journal of Mental Health and Addiction 20 (1) 152 (2022)
https://doi.org/10.1007/s11469-020-00347-4
Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance
Marine Tambon, Camille Ponté, Emilie Jouanjus, et al.Frontiers in Psychiatry 12 (2021)
https://doi.org/10.3389/fpsyt.2021.639780
Innovative approaches in CNS clinical drug development: Quantitative systems pharmacology
Clémence Lacroix, Thomas Soeiro, Marguerite Le Marois, Romain Guilhaumou, Catherine Cassé-Perrot, Elisabeth Jouve, Claas Röhl, Raoul Belzeaux, Joëlle Micallef and Olivier BlinTherapies 76 (2) 111 (2021)
https://doi.org/10.1016/j.therap.2020.12.007
Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network
Thomas Soeiro, Clémence Lacroix, Vincent Pradel, Maryse Lapeyre-Mestre and Joëlle MicallefFrontiers in Psychiatry 12 (2021)
https://doi.org/10.3389/fpsyt.2021.640120
Pregabalin Abuse in Combination With Other Drugs: Monitoring Among Methadone Patients
Massimo Lancia, Angela Gambelunghe, Alessio Gili, et al.Frontiers in Psychiatry 10 (2020)
https://doi.org/10.3389/fpsyt.2019.01022
Patterns of gabapentin and pregabalin use and misuse: Results of a population‐based cohort study in France
Damien Driot, Emilie Jouanjus, Stéphane Oustric, Julie Dupouy and Maryse Lapeyre‐MestreBritish Journal of Clinical Pharmacology (2019)
https://doi.org/10.1111/bcp.13892
Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution
Mathilde Dupui, Joëlle Micallef and Maryse Lapeyre-MestreTherapies 74 (2) 307 (2019)
https://doi.org/10.1016/j.therap.2018.09.078
Du médicament psychoactif à l’addictovigilance dans le Code de la santé publique en France (1990–2017)
Marie Baumevieille, Joëlle Perri-Plandé, Ghada Miremont-Salamé, Amélie Daveluy and Françoise HaramburuTherapies 74 (3) 375 (2019)
https://doi.org/10.1016/j.therap.2018.07.007